Call for Submissions

Program Participant Guidelines:

All abstract submissions are subject to the ACCME guidelines regarding independence and validation of clinical content. Instructors and authors are responsible for ensuring that (1) all recommendations involving clinical medicine presented are based on evidence that is accepted within the profession and (2) all scientific research referred to, reported, or used conforms to the generally accepted standards of experimental design, data collection, and analysis. Recommendations, treatments, or manners of practicing medicine that do not comply with the above, are known to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients will not be accepted.

ABSTRACT SUBMISSION PROCESS

Online abstract submission is open from August 26 to November 3, 2019.

• Enter details about the submission, refer to instructions by program for more details, including additional participants/contributors. All participants included in the submission will be notified and receive a link to complete the financial disclosure.
• All participants-presenters, coauthors, instructors, co-instructors, faculty, producers, and co-producers—must disclose their financial interests. The disclosure must be completed by November 3, 2019.
• Print or Save a copy of your submission.

PEER REVIEW PROCESS

All abstract submissions will be peer-reviewed by the World Cornea Congress (WCC) Program Committee. Abstract submissions will be evaluated on content and scientific integrity and will be accepted based on WCC creating an overall balanced program. Submissions by non-MDs/DOs will be reviewed in the context of the presenter’s training and education, as well as how the topic fits into the overall program. Abstract submissions should align with WCC educational objectives.

DISCLOSURE OF UNAPPROVED/OFF-LABEL USE

If a presentation concerns the use of a drug or device that has not been approved by the U.S. Food and Drug Administration or concerns off-label use of a drug or device approved by the FDA for other use, this must be disclosed during the presentation.

NOTIFICATION OF ABSTRACT ACCEPTANCE/NON-ACCEPTANCE

An e-mail with the status of the abstract submission will be sent by December 23 to the email listed for the primary author. If notification is not received by December 30, please contact: cbraden@ascrs.org.

REASONS FOR NON-ACCEPTANCE

The World Cornea Congress Program Committee will not accept abstracts under the following circumstances: 

• Abstract submissions that are commercially biased
• Abstract submissions from owners and/or employees of ACCME-defined commercial interests
• If the lead author and co-authors have not completed their individual ASCRS Faculty CME Review and Financial Interest Disclosure by the submission deadline
• If the submission’s content/research has been published or presented elsewhere. Abstracts submitted to both World Cornea Congress VIII and the ASCRS Annual Meeting 2020 will not be accepted.

SUBMISSION WITHDRAWLS

If an instructor/author/producer is unable to present, he/she must notify by e-mail, cbraden@ascrs.org.

CORNEA SOCIETY COPYRIGHT ASSIGNMENT STATEMENT

By submitting this abstract (paper or electronic poster), I agree to grant and assign exclusively to the Cornea Society (“the society”) all of the rights, including copyright, in the submitted presentation, as well as any related materials used for audiovisual presentation (collectively referred to as “the works”). I also grant and assign to the society the rights to film, record, reproduce, reprint, distribute, sell, and otherwise make use of the works, or any presentation of the works, in any media or format, and authorize the society to use my name, likeness, photograph, and biographical data in connection with its use and promotion of the works. I understand that I will receive no royalty or other monetary compensation from the society for this assignment of rights and the subsequent use of my works by the society.

I represent and warrant that the works are my own original work or that I have obtained all necessary permissions and authorizations from all individuals or entities that may otherwise have a right, title, or interest in the works; that I have full right and power to make this assignment; that the works do not violate any copyright, proprietary or personal rights of others; and that the works are factually accurate and contain no matter libelous or otherwise unlawful.